CHCI vs AAME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CHCI

28.1
AI Score
VS
AAME Wins

AAME

39.0
AI Score

Investment Advisor Scores

CHCI

28score
Recommendation
SELL

AAME

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CHCI AAME Winner
Revenue 40.03M 159.18M AAME
Net Income 8.85M 4.70M CHCI
Net Margin 22.1% 2.9% CHCI
ROE 10.9% 4.3% CHCI
ROA 9.6% 1.1% CHCI
Total Assets 92.18M 430.86M AAME
Cash 25.33M 34.44M AAME

Relative Price Performance (Last 90 Days)

CHCI 1M: +21.2% · 3M: +32.1% AAME 1M: -12.3% · 3M: -39.7%

Current Technical Phase

CHCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 66

RSI (14): 66.3 · Price: $18.28

AAME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.7%), weak momentum, RSI 31

RSI (14): 31.4 · Price: $1.35

Fundamentals Snapshot

Metric CHCI AAME
Market Cap
Forward P/E 12.9 7.4
Trailing P/E 8.0 5.8
Revenue (TTM)
Revenue Growth 0.7% 0.2%
Gross Margin 0.3% 0.1%
Operating Margin 0.3% 0.0%
EPS 2.31 0.23
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AAME is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.